Design
Review
Authors
Loading...
Antioxidant therapy should not yet change practice in atherosclerosis; leaves open whether restoring NO bioactivity improves outcomes.
This review discusses the role of oxidative stress in impairing endothelium-derived nitric oxide bioactivity and the potential for antioxidants to restore NO-dependent responses in atherosclerosis.
Douglas Tomasian (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: